Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.2 - $4.98 $7,865 - $17,803
3,575 New
3,575 $8,000
Q1 2023

May 09, 2023

BUY
$2.57 - $8.16 $902 - $2,864
351 Added 0.94%
37,580 $100,000
Q4 2022

Feb 14, 2023

BUY
$5.19 - $13.5 $193,218 - $502,591
37,229 New
37,229 $202,000
Q2 2022

Aug 15, 2022

SELL
$4.04 - $8.51 $171,829 - $361,947
-42,532 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$7.6 - $11.02 $28,059 - $40,685
-3,692 Reduced 7.99%
42,532 $323,000
Q4 2021

Feb 15, 2022

BUY
$10.16 - $16.17 $9,194 - $14,633
905 Added 2.0%
46,224 $472,000
Q3 2021

Nov 15, 2021

SELL
$13.16 - $22.47 $114,899 - $196,185
-8,731 Reduced 16.15%
45,319 $608,000
Q2 2021

Aug 16, 2021

BUY
$19.57 - $26.32 $51,136 - $68,774
2,613 Added 5.08%
54,050 $1.19 Million
Q1 2021

May 18, 2021

SELL
$17.58 - $32.59 $2,021 - $3,747
-115 Reduced 0.22%
51,437 $1.24 Million
Q3 2020

Nov 17, 2020

BUY
$11.55 - $23.75 $5,185 - $10,663
449 Added 0.88%
51,552 $595,000
Q1 2020

May 13, 2020

SELL
$9.07 - $26.32 $5,233 - $15,186
-577 Reduced 1.12%
51,103 $563,000
Q4 2019

Feb 14, 2020

SELL
$20.54 - $31.0 $22,285 - $33,635
-1,085 Reduced 2.06%
51,680 $1.37 Million
Q3 2019

Nov 15, 2019

BUY
$22.78 - $40.58 $15,285 - $27,229
671 Added 1.29%
52,765 $1.2 Million
Q2 2019

Aug 14, 2019

BUY
$16.03 - $31.1 $263,276 - $510,786
16,424 Added 46.04%
52,094 $1.6 Million
Q4 2018

Feb 13, 2019

BUY
$16.51 - $51.33 $62,490 - $194,284
3,785 Added 11.87%
35,670 $683,000
Q3 2018

Nov 14, 2018

BUY
$43.15 - $67.97 $28,392 - $44,724
658 Added 2.11%
31,885 $1.67 Million
Q2 2018

Aug 14, 2018

BUY
$35.06 - $51.17 $373,424 - $545,011
10,651 Added 51.76%
31,227 $1.36 Million
Q1 2018

May 15, 2018

BUY
$19.05 - $41.76 $153,847 - $337,253
8,076 Added 64.61%
20,576 $762,000
Q4 2017

Feb 14, 2018

SELL
$19.01 - $26.2 $5,703 - $7,860
-300 Reduced 2.34%
12,500 $248,000
Q3 2017

Nov 13, 2017

BUY
$12.53 - $27.12 $160,384 - $347,136
12,800
12,800 $319,000

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.